Direct‐injection high performance liquid chromatography ion trap mass spectrometry for the quantitative determination of olanzapine, clozapine and N‐desmethylclozapine in human plasma
- 28 May 2002
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 16 (13) , 1266-1272
- https://doi.org/10.1002/rcm.718
Abstract
A specific and sensitive direct‐injection high performance liquid chromatography electrospray ionization tandem mass spectrometry (HPLC/ESI‐MS/MS) method has been developed for the rapid identification and quantitative determination of olanzapine, clozapine, and N‐desmethylclozapine in human plasma. After the addition of the internal standard dibenzepin and dilution with 0.1% formic acid, plasma samples were injected into the LC/MS/MS system. Proteins and other large biomolecules were removed during an online sample cleanup using an extraction column (1 × 50 mm i.d., 30 µm) with a 100% aqueous mobile phase at a flow rate of 4 mL/min. The extraction column was subsequently brought inline with the analytical column by automatic valve switching. Analytes were separated on a 5 µm Symmetry C18 (Waters) analytical column (3.0 × 150 mm) with a mobile phase of acetonitrile/0.1% formic acid (20:80, v/v) at a flow rate of 0.5 mL/min. The total analysis time was 6 min per sample. The inter‐ and intra‐assay coefficients of variation for all compounds were <11%. By eliminating the need for extensive sample preparation, the proposed method offers very large savings in total analysis time. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 27 references indexed in Scilit:
- Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedureJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- The new generation of antipsychotic drugs: how atypical are they?International Journal of Neuropsychopharmacology, 2000
- Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London serviceEuropean Psychiatry, 2000
- Olanzapine Plasma Concentrations and Clinical Response in Acutely Ill Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1997
- Plasma Level Monitoring of Olanzapine in Patients With SchizophreniaTherapeutic Drug Monitoring, 1997
- Response of patients with treatment-refractory schizophrenia to clozapine within three serum level rangesAmerican Journal of Psychiatry, 1996
- Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Determination of Clozapine and its Major Metabolites in Serum Samples of Adolescent Schizophrenic Patients by High-Performance Liquid Chromatography - Data from a Prospective Clinical TrialPharmacopsychiatry, 1995
- Clozapine-Associated Agranulocytosis: Risk and AetiologyThe British Journal of Psychiatry, 1992